MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,570,392 shares; 2025Q1: 6,795,121 shares; 2025Q2: 6,795,121 shares; 2025Q3: 6,795,121 shares; 2025Q4: 6,795,121 shares; 2026Q1: 7,679,684 shares; 2026Q2: 7,679,684 shares; 2026Q3: 7,679,684 shares 7,679,684 $656M 16.29% 0 Timeline NAMS NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 15,916,418 shares; 2025Q1: 16,116,418 shares; 2025Q2: 16,607,074 shares; 2025Q3: 16,701,956 shares; 2025Q4: 16,943,774 shares; 2026Q1: 16,943,774 shares; 2026Q2: 18,088,902 shares; 2026Q3: 18,988,902 shares 18,988,902 $462M 11.46% +900,000 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 19,391,687 shares; 2025Q1: 22,575,851 shares; 2025Q2: 22,729,436 shares; 2025Q3: 22,729,436 shares; 2025Q4: 22,729,436 shares; 2026Q1: 24,675,188 shares; 2026Q2: 24,975,188 shares; 2026Q3: 29,475,188 shares 29,475,188 $432M 10.72% +4,500,000 Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,985,347 shares; 2025Q1: 5,985,347 shares; 2025Q2: 5,985,347 shares; 2025Q3: 6,652,013 shares; 2025Q4: 6,652,013 shares; 2026Q1: 6,652,013 shares; 2026Q2: 6,652,013 shares; 2026Q3: 6,652,013 shares 6,652,013 $390M 9.67% 0 Timeline ARQT ARCUTIS BIOTHERAPEUTICS INC More: the full row for ARCUTIS BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,785,284 shares; 2025Q1: 8,785,284 shares; 2025Q2: 9,874,511 shares; 2025Q3: 9,874,511 shares; 2025Q4: 9,874,511 shares; 2026Q1: 9,874,511 shares; 2026Q2: 9,874,511 shares; 2026Q3: 9,874,511 shares 9,874,511 $261M 6.48% 0 Timeline MAZE MAZE THERAPEUTICS INC More: the full row for MAZE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 4,129,001 shares; 2025Q2: 4,567,275 shares; 2025Q3: 4,567,274 shares; 2025Q4: 4,567,274 shares; 2026Q1: 4,567,274 shares; 2026Q2: 5,032,915 shares; 2026Q3: 5,282,915 shares 5,282,915 $144M 3.56% +250,000 Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,664,774 shares; 2025Q1: 10,259,409 shares; 2025Q2: 10,259,409 shares; 2025Q3: 10,259,409 shares; 2025Q4: 10,259,409 shares; 2026Q1: 9,939,547 shares; 2026Q2: 9,939,447 shares; 2026Q3: 9,539,147 shares 9,539,147 $137M 3.39% -400,300 Timeline KRYS KRYSTAL BIOTECH INC More: the full row for KRYSTAL BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 788,460 shares; 2025Q1: 688,460 shares; 2025Q2: 688,460 shares; 2025Q3: 688,460 shares; 2025Q4: 488,460 shares; 2026Q1: 481,307 shares; 2026Q2: 481,307 shares; 2026Q3: 391,319 shares 391,319 $130M 3.23% -89,988 Timeline PVLA PALVELLA THERAPEUTICS INC NE More: the full row for PALVELLA THERAPEUTICS INC NE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 653,892 shares; 2025Q1: 690,012 shares; 2025Q2: 722,400 shares; 2025Q3: 722,400 shares; 2025Q4: 722,400 shares; 2026Q1: 882,400 shares; 2026Q2: 882,400 shares; 2026Q3: 882,400 shares 882,400 $122M 3.02% 0 Timeline ATTO ATTOVIA THERAPEUTICS INC More: the full row for ATTOVIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,046,271 shares 7,046,271 $121M 3% new Timeline BRVE BRAVEHEART BIO INC More: the full row for BRAVEHEART BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,267,321 shares 5,267,321 $106M 2.64% new Timeline PHAT PHATHOM PHARMACEUTICALS INC More: the full row for PHATHOM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,109,279 shares; 2025Q1: 10,109,279 shares; 2025Q2: 12,466,489 shares; 2025Q3: 12,466,489 shares; 2025Q4: 12,466,489 shares; 2026Q1: 12,466,489 shares; 2026Q2: 12,466,489 shares; 2026Q3: 12,466,489 shares 12,466,489 $91M 2.26% 0 Timeline PBLS PARABILIS MEDICINES INC More: the full row for PARABILIS MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,920,805 shares; 2026Q3: 2,330,750 shares 2,330,750 $75.3M 1.87% +409,945 Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,443,341 shares; 2025Q2: 1,505,984 shares; 2025Q3: 2,718,105 shares; 2025Q4: 3,153,082 shares; 2026Q1: 3,153,082 shares; 2026Q2: 3,153,082 shares; 2026Q3: 3,853,082 shares 3,853,082 $62.1M 1.54% +700,000 Timeline ACHV ACHIEVE LIFE SCIENCE INC More: the full row for ACHIEVE LIFE SCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 7,614,836 shares; 2026Q3: 7,614,836 shares 7,614,836 $61.6M 1.53% 0 Timeline MNKD MANNKIND CORP More: the full row for MANNKIND CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,225,000 shares; 2026Q1: 5,900,000 shares; 2026Q2: 6,600,000 shares; 2026Q3: 15,755,491 shares 15,755,491 $61.4M 1.52% +9,155,491 Timeline IRON DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,754,834 shares; 2025Q1: 1,754,834 shares; 2025Q2: 1,654,834 shares; 2025Q3: 1,438,534 shares; 2025Q4: 1,260,000 shares; 2026Q1: 1,354,852 shares; 2026Q2: 1,354,852 shares; 2026Q3: 934,852 shares 934,852 $61.2M 1.52% -420,000 Timeline TARS TARSUS PHARMACEUTICALS INC More: the full row for TARSUS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,587,527 shares; 2025Q1: 1,397,527 shares; 2025Q2: 1,397,527 shares; 2025Q3: 1,167,527 shares; 2025Q4: 728,644 shares; 2026Q1: 728,644 shares; 2026Q2: 728,644 shares; 2026Q3: 720,338 shares 720,338 $56.6M 1.4% -8,306 Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,543,939 shares; 2026Q1: 2,543,939 shares; 2026Q2: 2,543,939 shares; 2026Q3: 2,743,939 shares 2,743,939 $52.4M 1.3% +200,000 Timeline ASND ASCENDIS PHARMA A/S More: the full row for ASCENDIS PHARMA A/S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 225,155 shares 225,155 $51.3M 1.27% new Timeline ZLAB ZAI LAB LTD More: the full row for ZAI LAB LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 350,000 shares; 2025Q2: 1,308,138 shares; 2025Q3: 1,627,320 shares; 2025Q4: 1,902,320 shares; 2026Q1: 1,902,320 shares; 2026Q2: 1,902,320 shares; 2026Q3: 1,902,320 shares 1,902,320 $50.1M 1.24% 0 Timeline ACRS ACLARIS THERAPEUTICS INC More: the full row for ACLARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,925,374 shares; 2026Q2: 4,925,374 shares; 2026Q3: 8,729,516 shares 8,729,516 $45.9M 1.14% +3,804,142 Timeline AURA AURA BIOSCIENCES INC More: the full row for AURA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,100,000 shares; 2025Q3: 5,100,000 shares; 2025Q4: 5,100,000 shares; 2026Q1: 5,100,000 shares; 2026Q2: 7,100,000 shares; 2026Q3: 7,100,000 shares 7,100,000 $44.6M 1.11% 0 Timeline ALLO ALLOGENE THERAPEUTICS INC More: the full row for ALLOGENE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,867,750 shares; 2025Q1: 3,868,750 shares; 2025Q2: 3,868,750 shares; 2025Q3: 3,868,750 shares; 2025Q4: 3,868,750 shares; 2026Q1: 3,796,668 shares; 2026Q2: 22,446,668 shares; 2026Q3: 22,446,668 shares 22,446,668 $35.9M 0.89% 0 Timeline BCRX BIOCRYST PHARMACEUTICALS INC More: the full row for BIOCRYST PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,009,240 shares; 2026Q2: 4,009,240 shares; 2026Q3: 4,009,240 shares 4,009,240 $33.4M 0.83% 0 Timeline CLDX CELLDEX THERAPEUTICS INC NEW More: the full row for CELLDEX THERAPEUTICS INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 900,080 shares 900,080 $29.2M 0.72% new Timeline ACAD ACADIA PHARMACEUTICALS INC More: the full row for ACADIA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 470,338 shares; 2025Q1: 470,338 shares; 2025Q2: not reported; 2025Q3: 613,837 shares; 2025Q4: 1,297,198 shares; 2026Q1: 1,438,198 shares; 2026Q2: 1,438,198 shares; 2026Q3: 1,438,198 shares 1,438,198 $29M 0.72% 0 Timeline STTK SHATTUCK LABS INC More: the full row for SHATTUCK LABS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,750,000 shares; 2026Q3: 3,750,000 shares 3,750,000 $25.6M 0.63% 0 Timeline IMCR IMMUNOCORE HLDGS PLC More: the full row for IMMUNOCORE HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 108,762 shares; 2025Q1: 301,170 shares; 2025Q2: 384,782 shares; 2025Q3: 384,782 shares; 2025Q4: 384,782 shares; 2026Q1: 484,782 shares; 2026Q2: 484,782 shares; 2026Q3: 829,752 shares 829,752 $25.1M 0.62% +344,970 Timeline DSGN DESIGN THERAPEUTICS INC More: the full row for DESIGN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,953,547 shares; 2025Q1: 1,953,547 shares; 2025Q2: 1,953,547 shares; 2025Q3: 1,953,547 shares; 2025Q4: 521,000 shares; 2026Q1: not reported; 2026Q2: 1,809,854 shares; 2026Q3: 1,809,854 shares 1,809,854 $22.7M 0.56% 0 Timeline EOLS EVOLUS INC More: the full row for EVOLUS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,435,550 shares; 2025Q3: 2,630,665 shares; 2025Q4: 2,630,665 shares; 2026Q1: 2,630,665 shares; 2026Q2: 2,630,665 shares; 2026Q3: 2,630,665 shares 2,630,665 $21M 0.52% 0 Timeline SRPT SAREPTA THERAPEUTICS INC More: the full row for SAREPTA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,069,959 shares 1,069,959 $19.5M 0.48% new Timeline RLAY RELAY THERAPEUTICS INC More: the full row for RELAY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,015,693 shares; 2026Q3: 1,015,693 shares 1,015,693 $18.3M 0.45% 0 Timeline LXEO LEXEO THERAPEUTICS INC More: the full row for LEXEO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 955,515 shares; 2025Q1: 955,515 shares; 2025Q2: 4,424,725 shares; 2025Q3: 4,424,725 shares; 2025Q4: 4,424,725 shares; 2026Q1: 4,424,725 shares; 2026Q2: 4,824,725 shares; 2026Q3: 4,824,725 shares 4,824,725 $16.3M 0.4% 0 Timeline VALN VALNEVA SE More: the full row for VALNEVA SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,458,333 shares; 2025Q3: 2,291,666 shares; 2025Q4: 2,291,666 shares; 2026Q1: 2,291,666 shares; 2026Q2: 2,291,666 shares; 2026Q3: 2,291,666 shares 2,291,666 $14.2M 0.35% 0 Timeline KLRA KAILERA THERAPEUTICS INC More: the full row for KAILERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,100,000 shares; 2026Q3: 1,200,000 shares 1,200,000 $13.7M 0.34% +100,000 Timeline GLUE MONTE ROSA THERAPEUTICS INC More: the full row for MONTE ROSA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $11.9M 0.3% 0 Timeline ORIC ORIC PHARMACEUTICALS INC More: the full row for ORIC PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,888,238 shares; 2025Q1: 1,410,193 shares; 2025Q2: 1,065,334 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 751,672 shares 751,672 $10.1M 0.25% new Timeline AUTL AUTOLUS THERAPEUTICS LTD More: the full row for AUTOLUS THERAPEUTICS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,623,324 shares; 2025Q1: 4,623,324 shares; 2025Q2: 4,623,324 shares; 2025Q3: 4,623,324 shares; 2025Q4: 4,623,324 shares; 2026Q1: 4,447,910 shares; 2026Q2: 4,447,910 shares; 2026Q3: 4,447,910 shares 4,447,910 $8.63M 0.21% 0 Timeline NAMSW NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,333 shares; 2025Q1: 500,333 shares; 2025Q2: 500,333 shares; 2025Q3: 500,333 shares; 2025Q4: 500,333 shares; 2026Q1: 500,333 shares; 2026Q2: 500,333 shares; 2026Q3: 500,333 shares 500,333 $6.33M 0.16% 0 Timeline SVRA SAVARA INC More: the full row for SAVARA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,660,379 shares; 2025Q1: 11,462,301 shares; 2025Q2: 11,462,301 shares; 2025Q3: 11,462,301 shares; 2025Q4: 9,862,301 shares; 2026Q1: 9,720,852 shares; 2026Q2: 9,720,852 shares; 2026Q3: 1,113,752 shares 1,113,752 $5.75M 0.14% -8,607,100 Timeline XLO XILIO THERAPEUTICS INC More: the full row for XILIO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 422,505 shares; 2026Q2: 422,505 shares; 2026Q3: 422,505 shares 422,505 $3.82M 0.09% 0 Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $3.75M 0.09% new Timeline IBIO IBIO INC More: the full row for IBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,953,467 shares; 2026Q1: 1,953,467 shares; 2026Q2: 1,953,467 shares; 2026Q3: 1,953,467 shares 1,953,467 $2.31M 0.06% 0 Timeline